Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.

Bielinski C, Luu HS, Mau T.

Otolaryngol Head Neck Surg. 2014 Feb;150(2):334-5. doi: 10.1177/0194599813515632. Epub 2013 Dec 13. No abstract available.

PMID:
24334958
2.

Subglottic stenosis induced by extranodal mucosa-associated lymphoid tissue lymphoma.

Kuo JR, Hou YY, Chu ST, Chien CC.

J Chin Med Assoc. 2011 Mar;74(3):144-7. doi: 10.1016/j.jcma.2011.01.032. Epub 2011 Feb 22.

3.

Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.

Arndt S, Veelken H, Schmitt-Gräff A, Aschendorff A, Maier W, Richter B.

Ann Otol Rhinol Laryngol. 2007 Apr;116(4):257-61.

PMID:
17491523
4.

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.

Raderer M, Jäger G, Brugger S, Püspök A, Fiebiger W, Drach J, Wotherspoon A, Chott A.

Oncology. 2003;65(4):306-10.

PMID:
14707449
5.

Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.

Okamura I, Imai H, Mori K, Ogura K, Isoda A, Mihara K, Matsumoto M, Saito R, Takahashi T, Ikeda T.

Int J Hematol. 2015 Jan;101(1):46-51. doi: 10.1007/s12185-014-1694-8. Epub 2014 Nov 7.

PMID:
25378228
6.

[Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case].

Yoshida C, Tarumi S, Kato A, Nii K, Chang SS, Yokomise H.

Kyobu Geka. 2013 Feb;66(2):169-72. Japanese.

PMID:
23381369
7.

Treatment of localized oral MALT lymphoma by rituximab: a case report.

Yamagata K, Onizawa K, Kojima H, Yoshida H.

Oral Maxillofac Surg. 2008 Dec;12(4):227-30. doi: 10.1007/s10006-008-0135-3. Epub 2008 Oct 2.

PMID:
18830723
8.

Cytotoxic T cell-mediated gastritis after rituximab treatment for gastric malt lymphoma.

Stalika E, Kanellis G, Papalexandri A, Iskas M, Vrakidou E, Demonakou M, Anagnostopoulos A, Stamatopoulos K, Papadaki T.

Leuk Lymphoma. 2014 Mar;55(3):702-5. doi: 10.3109/10428194.2013.810736. Epub 2013 Jul 29. No abstract available.

PMID:
23725385
9.

Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.

Troch M, Kiesewetter B, Dolak W, Jaeger U, Püspök A, Müllauer L, Chott A, Raderer M.

Ann Hematol. 2012 May;91(5):723-8. doi: 10.1007/s00277-011-1387-9. Epub 2011 Dec 22.

PMID:
22186828
10.

Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.

Ferreri AJ, Govi S, Colucci A, Crocchiolo R, Modorati G.

Ophthalmology. 2011 Jan;118(1):24-8. doi: 10.1016/j.ophtha.2010.04.036. Epub 2010 Aug 14.

PMID:
20709407
11.

Mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus.

Tsujii Y, Nishida T, Kato M, Inoue T, Yamamoto S, Hayashi Y, Akasaka T, Kondo J, Yamada T, Shinzaki S, Iijima H, Tsujii M, Takehara T.

Dis Esophagus. 2013 Apr;26(3):349-50. doi: 10.1111/j.1442-2050.2012.01387.x. Epub 2012 Aug 7. No abstract available.

PMID:
22882544
12.

Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma.

Biondo F, Matturro A, Santoro C, Leporace A, D'Elia G, Baldacci E, Pignoloni P, Pulsoni A, Foà R, Mazzucconi M.

Haemophilia. 2012 Jan;18(1):e34-5. doi: 10.1111/j.1365-2516.2011.02681.x. Epub 2011 Nov 8. No abstract available.

PMID:
22059776
13.

Subglottic tracheal stenosis as primary manifestation of a marginal zone B-cell lymphoma of the larynx.

Andratschke M, Stelter K, Ihrler S, Hagedorn H.

In Vivo. 2005 May-Jun;19(3):547-50.

14.

[Mucosa-associated lymphoid tissue lymphoma of the larynx].

Hua J, Iwaki Y, Inoue M, Takiguchi Y, Ota Y, Hagihara M.

Rinsho Ketsueki. 2014 Mar;55(3):340-4.

PMID:
24681938
15.

[Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].

Kagawa M, Okamura S, Okamoto K, Kitamura S, Kimura T, Niki M, Kaji M, Okahisa T, Yano M, Kagawa S, Kudo E, Sano T, Imoto Y, Wada S, Takayama T.

Nihon Shokakibyo Gakkai Zasshi. 2010 Apr;107(4):612-9. Japanese.

PMID:
20379095
16.

Orbital lymphoma masquerading as panuveitis.

Panda P, Forooghian F, Goodglick T, Chan CC, Nussenblatt R, Sen HN.

Ocul Immunol Inflamm. 2010 Jun;18(3):181-3. doi: 10.3109/09273941003728947.

17.

[Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sjögren syndrome].

Iwabuchi T, Kimura Y, Suzuki T, Hayashi H, Fujimoto H, Hashimoto Y, Ogawa T, Kusama H, Fukutake K, Ohyashiki K.

Rinsho Ketsueki. 2011 Apr;52(4):210-5. Japanese.

PMID:
21566407
18.

Expect the unexpected: primary breast MALT lymphoma.

Ghetu D, Membrez V, Bregy A, Vees HG, Hottelier D, Girardet C, Schneider N, Bieri S.

Arch Gynecol Obstet. 2011 Nov;284(5):1323-4. doi: 10.1007/s00404-011-2015-6. Epub 2011 Jul 29. No abstract available.

PMID:
21800083
19.

Pleuric presentation of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report and a review of the literature.

Motta G, Conticello C, Amato G, Moschetti G, Colarossi C, Cosentino S, Ippolito M, Giustolisi R, Di Raimondo F.

Int J Hematol. 2010 Sep;92(2):369-73. doi: 10.1007/s12185-010-0645-2. Epub 2010 Aug 20. Review.

PMID:
20725816
20.

Case report: Colonic MALT lymphoma.

Khan M, Chon D, Patil A.

J Gastrointest Cancer. 2012 Dec;43(4):622-5. doi: 10.1007/s12029-012-9420-3. No abstract available.

PMID:
22965352
Items per page

Supplemental Content

Write to the Help Desk